Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

APOTEX

  • FDA Approval
  • Sept. 18, 2025, 08:53 UTC
  • 43
  • 0 comments

FDA approve GEMCITABINE HYDROCHLORIDE

Comment Full text

CHARTWELL MOLECULAR

  • FDA Approval
  • Sept. 18, 2025, 08:53 UTC
  • 45
  • 0 comments

FDA approve LANSOPRAZOLE

Comment Full text

ORBION PHARMS

  • FDA Approval
  • Sept. 18, 2025, 08:53 UTC
  • 75
  • 0 comments

FDA approve TERBINAFINE HYDROCHLORIDE

Comment Full text

UNICHEM

  • FDA Approval
  • Sept. 18, 2025, 08:53 UTC
  • 48
  • 0 comments

FDA approve IRBESARTAN

Comment Full text

LUPIN LTD

  • FDA Approval
  • Sept. 18, 2025, 08:53 UTC
  • 44
  • 0 comments

FDA approve LENALIDOMIDE

Comment Full text

ALEMBIC PHARMS LTD

  • FDA Approval
  • Sept. 18, 2025, 08:53 UTC
  • 46
  • 0 comments

FDA approve IRBESARTAN

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 18, 2025, 08:53 UTC
  • 48
  • 0 comments

FDA approve QUETIAPINE FUMARATE

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Sept. 18, 2025, 08:53 UTC
  • 47
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

PHARMOBEDIENT

  • FDA Approval
  • Sept. 18, 2025, 08:53 UTC
  • 47
  • 0 comments

FDA approve FEBUXOSTAT

Comment Full text

LUPIN LTD

  • FDA Approval
  • Sept. 18, 2025, 08:53 UTC
  • 51
  • 0 comments

FDA approve IRBESARTAN

Comment Full text
  • Previous
  • 86
  • 87
  • 88
  • 89
  • 90
  • Next

Search

News categories

  • Technical Exchange News(13441)
  • Event(6229)
  • SEC News(346193)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(191342)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin